Research Journal of Pharmacy and Technology
SCOPUS
  • Year: 2022
  • Volume: 15
  • Issue: 11

Synthesis and genotoxic evaluation of a 4- (Oxiran-2-ylmethyl)-1,4-benzothiazin-3-one

  • Author:
  • Hassan Jaddi1,2,*, Moussaif Ahmed1, Laila Benbacer1, Attaleb Mohammed1, Ellouz Mohamed2, Kheira Sebbar Nada2, Filali Maltouf Abdelkarim2, El Mokhtar Essassi2, El Mzibri Mohammed1
  • Total Page Count: 8
  • Page Number: 5217 to 5224

1Life Science Division, National Center for Energy, Sciences and Nuclear Techniques, Rabat, Morocco

2Faculty of Sciences, Mohammed V University, Rabat, Morocco

*Corresponding Author E-mail: jaddi_hassan@yahoo.fr

Online published on 3 March, 2023.

Abstract

A new benzothiazine: 4-(oxiran-2-ylmethyl)-1,4-benzothiazin-3-one was synthesized by a liquid-solid phase transfer catalysis reaction. The new compound was well characterized by FT-IR spectroscopy, the nuclear resonance of proton and carbon 13, and mass spectrometry. The genotoxicity of the new benzothiazine derivative was assessed using the micronucleus assay on Chinese Hamster Ovary cells (CHO cells), as compared to its cytotoxicity against CHO cells. Accordingly, the chromosomal damages were detected with micronucleus frequency (MN) and cytotoxicity was assessed with cyto-blocking proliferation index (CBPI). The newly synthesized benzothiazine derivative was not cytotoxic and don't exhibit, in absence of metabolic activation, any genotoxic effect, making it a potential chemical for further biological explorations and an interesting scaffold for new derivatives.

Keywords

Benzothiazine, Heterocycle, Micronucleus test, Genotoxicity, Catalysis